Search

Your search keyword '"Biotechnology industry -- Cases -- Intellectual property"' showing total 145 results
Start Over Descriptor "Biotechnology industry -- Cases -- Intellectual property"
145 results on '"Biotechnology industry -- Cases -- Intellectual property"'

1. Amgen Files BPCIA Complaint Against Fresenius Kabi Regarding Denosumab

Author

Herron, R. Samuel

Subjects
Amgen Inc. -- Cases -- Intellectual property, Fresenius Kabi AG -- Cases, Denosumab -- Cases -- Intellectual property, Medical test kit industry -- Cases, Biotechnology industry -- Cases -- Intellectual property, Medical equipment and supplies industry -- Cases, Patent infringement -- Cases, Company legal issue, Business, international, Biologics Price Competition and Innovation Act of 2009
Abstract

On October 4, 2024, Amgen filed a BPCIA complaint in the District Court for the Northern District of Illinois Eastern Division against Fresenius Kabi related to Fresenius Kabi's proposed biosimilar [...]

Published
2024

2. Genzyme Sues Sarepta For Infringement Of Gene Therapy Patents

Author

Cassella, Christopher

Subjects
Genzyme Corp. -- Cases -- Intellectual property, Gene therapy -- Cases -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Patent infringement -- Cases, Company legal issue, Business, international
Abstract

On July 26, 2024, Genzyme Corp. (a wholly owned subsidiary of Sanofi) filed suit in the District Court for the District of Delaware against Sarepta Therapeutics, Inc., and Sarepta Therapeutics [...]

Published
2024

3. Moderna sues Pfizer-BioNTech, alleging coronavirus vaccine patent infringement

Author

Rowland, Christopher

Subjects
BioNTech SE -- Cases, Pfizer Inc. -- Cases, Moderna Inc. -- Cases -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Patent infringement -- Cases, Pharmaceutical industry -- Cases, Company legal issue, General interest, News, opinion and commentary, Spikevax (Vaccine) -- Intellectual property
Abstract

Byline: Christopher Rowland Moderna said it sued Pfizer and its German partner BioNTech on Friday, alleging the rival firms improperly used its foundational technology in developing their coronavirus vaccine. The [...]

Published
2022

4. District Court Permits Damage Expert To Testify Regarding Comparable Licenses That Contained 'Built-In Apportionment' Of Royalties

Author

Gibson, Stanley

Subjects
Laboratory Corporation of America Holdings -- Cases -- Intellectual property, Medical tests -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Health care industry -- Cases -- Intellectual property, Royalties -- Laws, regulations and rules, Patent infringement -- Cases, Company legal issue, Health care industry, Government regulation, Business, international
Abstract

In this patent infringement action, Ravgen asserted that Labcorp infringes claims of its 727,720 and 7,332,277 patents (the ''720' and ''277' patents through four cell-free DNA-based tests, each of which [...]

Published
2022

5. Canadian biopharma firms spar over key tech in vaccines

Author

O'Kane, Josh

Subjects
Pfizer Inc. -- Cases -- Intellectual property, Arbutus Biopharma Corp. -- Cases -- Intellectual property, Moderna Inc. -- Cases -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Patent infringement -- Cases, Pharmaceutical industry -- Cases -- Intellectual property, Company legal issue, General interest, News, opinion and commentary
Abstract

Byline: JOSH O'KANE; Staff TECHNOLOGY REPORTER A complex web of inventors, companies and their patent holders from the Vancouver area are trying to stake claims in inventions that have saved [...]

Published
2022

6. Moderna halts patent fight over coronavirus vaccine with federal government

Author

Diamond, Dan

Subjects
United States. National Institutes of Health -- Cases, Moderna Inc. -- Cases -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Medically underserved areas, Patents -- Cases, Company legal issue, Patent/copyright issue, Company distribution practices, General interest, News, opinion and commentary, Spikevax (Vaccine) -- Cases -- Distribution -- Dosage and administration -- Intellectual property
Abstract

Byline: Dan Diamond Moderna is pausing a patent dispute with the federal government over its groundbreaking coronavirus vaccine, saying it is 'grateful' to government scientists who collaborated with the company [...]

Published
2021

7. Judge Albright Grants Motion To Dismiss AI Patent Claims On § 101 Grounds

Author

Santoro, Gianna

Subjects
Health Discovery Corp. -- Cases -- Intellectual property, Intel Corp. -- Cases -- Intellectual property, Semiconductor industry -- Cases -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Patent infringement -- Cases, Company legal issue, Semiconductor industry, Business, international
Abstract

In Health Discovery Corp. v. Intel Corp., Judge Alan Albright granted, in part, Intel's motion to dismiss infringement claims of AI machine-learning patents on § 101 grounds. The court did [...]

Published
2022

8. Kite Flies Away With CAR-T Patent Challenge Win Based On Written Description Battle

Subjects
Biotechnology industry -- Cases -- Intellectual property, Patent infringement -- Cases, Pharmaceutical industry -- Cases -- Intellectual property, Company legal issue, Business, international
Abstract

In Juno Therapeutics v. Kite Pharma, the Court of Appeals for the Federal Circuit (CAFC) reversed a $1.2 billion dollar judgment to Juno, finding that Juno's asserted claims, which they [...]

Published
2021

10. IPTimes.Law: April 2021 Issue

Author

Rao, Dipak

Subjects
Biotechnology industry -- Cases -- Intellectual property, Patent infringement -- Cases, Pharmaceutical industry -- Cases -- Intellectual property, Company legal issue, Business, international
Abstract

Welcome to the April 2021 Issue of legal news in the field of Intellectual Property Rights by Singhania & Partners. This issue summarizes the latest news and provides a quick [...]

Published
2021

11. Diagnostic methods patentable in Australia

Author

Fixler, David

Subjects
Sequenom Inc. -- Cases -- Intellectual property, Patentability -- Cases, Diagnostic services -- Cases -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Company legal issue, Business, international
Abstract

In Ariosa Diagnostics Inc v Sequenom Inc [2021] FCAFC 101, the Full Federal Court of Australia (Full Court) confirmed the patentability of genetic based diagnostic method claims. As with other [...]

Published
2021

12. A High Bar For Antibody Genus Claims To Meet The Enablement Requirement

Author

Sun, Lin

Subjects
Amgen Inc. -- Cases -- Intellectual property, Sanofi S.A. -- Cases -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Patent infringement -- Cases, Pharmaceutical industry -- Cases -- Intellectual property, Company legal issue, Business, international
Abstract

The United States Court of Appeals for the Federal Circuit recently issued its opinion in Amgen v. Sanofi, finding Amgen's antibody claims invalid for lack of enablement.1 The Federal Circuit [...]

Published
2021

13. Regeneron Recast - Mr Justice Birss Provides Illuminating Insight Into The Law Of Sufficiency

Subjects
Nucleotide sequencing -- Intellectual property, DNA sequencing -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Health care industry -- Cases -- Intellectual property, Judges -- Beliefs, opinions and attitudes -- Powers and duties, Patent infringement -- Cases, Company legal issue, Health care industry, Business, international
Abstract

On 20 January 2021, Mr Justice Birss handed down judgment in Illumina v Latvia MGI Tech & Ors.1 In a lengthy judgment reaching over 500 paragraphs, Birss J found four [...]

Published
2021

14. Where patent dispute is pending at European and Japanese patent offices, Ninth Circuit permits the gathering of evidence in the U.S. for those proceedings pursuant to § 1782

Subjects
United States. Court of Appeals for the 9th Circuit -- Cases, FibroGen Inc. -- Cases -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Patent infringement -- Cases, Company legal issue, International relations, Law
Abstract

FibroGen, Inc. (FibroGen), a biotechnology company based in San Francisco, California, owns several foreign patents regarding chemical compounds useful for treating anemias. Akebia Therapeutics, Inc. (Akebia), a biopharmaceutical company that [...]

Published
2015

15. Sweeping patents put biotech companies on warpath

Author

Stone, Richard

Subjects
Biotechnology industry -- Cases -- Intellectual property, Genetic engineering -- Intellectual property -- Cases, Patents -- Cases, Science and technology, Company legal issue, Patent/copyright issue, Intellectual property, Cases
Abstract

In October 1992, the U.S. Patent and Trademark Office (PTO) stunned the agricultural biotechnology community by awarding a patent to a single company, Agracetus Inc. of Middleton, Wisconsin, for rights [...]

Published
1995

16. DR REDDY'S FACES PATENT SUIT OVER CANCER DRUG (the suit has been filed by Genzyme Corporation)

Subjects
Genzyme Corp. -- Cases -- Intellectual property, Antineoplastic agents -- Cases, Generic drugs -- Cases, Biotechnology industry -- Cases -- Intellectual property, Cancer -- Care and treatment, Drug approval -- Cases, Patent infringement -- Cases, Antimitotic agents -- Cases, Company legal issue, Banking, finance and accounting industries, Business, Business, international, News, opinion and commentary
Abstract

A suit has been filed against Dr Reddy's Laboratories (DRL) by Genzyme Corporation alleging that DRL has infringed patents of its blockbuster cancer drug Mozobil on three counts. Genzyme Corporation [...]

Published
2013

17. Roche Dealt a Setback On European Taq Patent

Author

SERVICE, ROBERT F.

Subjects
Hoffmann-La Roche AG -- Cases -- Intellectual property, Cetus Corp. -- Cases -- Intellectual property, Promega Corp. -- Cases -- Intellectual property, European Patent Organisation. European Patent Office -- Cases, Biochemistry -- Cases, Biological products industry -- Cases -- Intellectual property, Patent law -- Cases, Biological products -- Cases, Chemistry -- Cases, Biotechnology industry -- Cases -- Intellectual property, DNA polymerases -- Intellectual property -- Cases, Science and technology, Company legal issue, Intellectual property, Cases
Abstract

A key biotechnology patent belonging to Swiss pharmaceutical giant Hoffmann-La Roche ran aground on the legal shoals of a third continent last week. On 30 May the European Patent Office [...]

Published
2001

18. Teva Comments on Patent Infringement Lawsuit Filed by Momenta and Sandoz

Subjects
United States. Food and Drug Administration -- Cases, Momenta Pharmaceuticals Inc. -- Cases -- Intellectual property, Sandoz Inc. -- Cases -- Intellectual property, Generic drugs -- Cases, Biotechnology industry -- Cases -- Intellectual property, Patent infringement -- Cases, Pharmaceutical industry -- Cases -- Intellectual property, Company legal issue, Health, Women's issues/gender studies, Lovenox (Medication)
Abstract

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) commented today on the patent infringement lawsuit filed by Momenta Pharmaceuticals, Inc. and Sandoz Inc (see also Teva Pharmaceutical Industries Ltd.). Teva received a [...]

Published
2010

19. Supreme Court Rules Against Patents On Human Genes - U

Subjects
United States. Supreme Court -- Cases, Biotechnology industry -- Cases -- Intellectual property, Patents -- Cases, Company legal issue, Patent/copyright issue, Myriad Genetics Inc. -- Cases -- Intellectual property
Abstract

To listen to this broadcast, click here: http://www.npr.org/templates/story/story.php?storyId=191400438 BLOCK: The Supreme Court ruled unanimously today that human genes cannot be patented. The decision is expected to have an enormous effect […]

Published
2013

20. Justice Dept. Opts Out of Whistle-Blower Suit

Author

Brainard, Jeffrey

Subjects
California Institute of Technology -- Cases -- Intellectual property, Patent law -- Cases, Biotechnology industry -- Cases -- Intellectual property, Universities and colleges -- Cases -- Intellectual property -- United States, Company legal issue
Published
2002

21. Monsanto Settles Patent Suits

Author

SEEWALD, NANCY

Subjects
Dow AgroSciences L.L.C. -- Cases, Pioneer Hi-Bred International Inc. -- Cases -- Intellectual property, E.I. du Pont de Nemours and Co. -- Cases -- Intellectual property, DEKALB Genetics Corp. -- Cases -- Intellectual property, Monsanto Co. -- Cases -- Intellectual property, Plant genetics -- Cases, Biotechnology industry -- Cases -- Intellectual property, Agricultural chemicals industry -- Cases -- Intellectual property, Breach of contract -- Cases, Bacillus thuringiensis -- Intellectual property -- Cases, Agricultural chemicals -- Cases, Business, Chemicals, plastics and rubber industries, Company legal issue, Intellectual property, Cases
Abstract

MONSANTO SUBSIDIARY DEKALB GENETICS SAYS THAT IT HAS settled a patent dispute it filed against Dow AgroSciences related to the use of Bacillus thuringiensis (Bt) insect-resistance technology in corn. DeKalb [...]

Published
2001

22. Biotech firms battle over patents

Subjects
Affymetrix Inc. -- Intellectual property -- Cases, Incyte Corp. -- Intellectual property -- Cases, Biochemistry -- Cases, Biotechnology industry -- Cases -- Intellectual property, Genetic engineering -- Cases, Company legal issue, Business, Business, regional
Abstract

Palo Alto-based Incyte Genomics Inc. announced that it has filed a patent infringement suit against Affymetrix Inc. in the U.S. District Court of Northern California. The suit alleges Affymetrix of [...]

Published
2000

23. The U.S. Supreme Court takes on gene patents: is your genetic information an invention or a discovery? And what difference will that make?

Author

Mayes, Randall

Subjects
United States. Patent and Trademark Office -- Cases, United States. Supreme Court -- Cases, Myriad Genetics Inc. -- Cases -- Intellectual property, Patentability -- Cases, Patent licenses -- Cases, Biotechnology industry -- Cases -- Intellectual property, Genetic engineering -- Cases, Company legal issue, Business, general, Sociology and social work, Association for Molecular Pathology v. Patent & Trademark Office 689 F.3d 1303 (Fed. Cir. 2012), American Civil Liberties Union -- Cases
Abstract

When you think of technology--lifesaving drugs, cars, electronics, etc.--Japan, western Europe, and the United States come to mind. These highly developed regions of the world have public-private infrastructures that include [...]

Published
2013

24. Should we patent human genes? The Supreme Court ponders the intersection of biology and intellectual property

Author

Bailey, Ronald

Subjects
United States. Supreme Court -- Cases, Myriad Genetics Inc. -- Cases -- Intellectual property, Trade and professional associations -- Cases, Genes -- Cases, Human genetics -- Cases, Biotechnology industry -- Cases -- Intellectual property, Patents -- Cases, Company legal issue, Patent/copyright issue, Humanities, Philosophy and religion, Political science, Association for Molecular Pathology v. Myriad Genetics, Inc. 133 S. Ct. 2107 (2013), American Civil Liberties Union -- Cases
Abstract

SHOULD HUMAN DNA be patentable? That's the central question in Association for Molecular Pathology v. Myriad Genetics, a case argued before the U.S. Supreme Court in April. The lawsuit was [...]

Published
2013

25. Can medical companies patent human genes? Supreme Court hears key case

Author

Richey, Warren

Subjects
United States. Supreme Court -- Cases, Myriad Genetics Inc. -- Cases -- Intellectual property, Genes -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Patents -- Cases, Company legal issue, Patent/copyright issue, General interest, News, opinion and commentary, American Civil Liberties Union -- Cases
Abstract

Byline: Warren Richey The US Supreme Court is scheduled on Monday to take up a case with widespread implications for scientific innovation and health care in the US. The question: [...]

Published
2013

26. Justices Send Back Gene Case

Author

Pollack, Andrew

Subjects
United States. Supreme Court -- Cases, Myriad Genetics Inc. -- Cases -- Intellectual property, Blood -- Medical examination, Patent law -- Interpretation and construction, Genes -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Company legal issue, General interest, News, opinion and commentary
Abstract

The Supreme Court on Monday ordered an appeals court to reconsider its decision to uphold patents held by Myriad Genetics on two genes associated with a high risk of breast [...]

Published
2012

27. BRIEF: Isis Pharma files patent suit against Santaris

Subjects
Santaris Pharma A/S -- Cases -- Intellectual property, Ionis Pharmaceuticals, Inc. -- Cases -- Intellectual property, Drugs -- Vehicles, Biotechnology industry -- Cases -- Intellectual property, Patent infringement -- Cases, Drug delivery systems -- Cases, Pharmaceutical industry -- Cases -- Intellectual property, Company legal issue, Business, General interest, Business, regional
Abstract

Byline: Bradley J. Fikes Sept. 23--Isis Pharmaceuticals Inc. said Friday it has filed a patent infringement lawsuit against Santaris Pharma A/S and Santaris Pharma A/S Corp. Isis filed the suit [...]

Published
2011

28. Teva wins ruling on Copaxone patent lawsuit

Subjects
Momenta Pharmaceuticals Inc. -- Cases -- Intellectual property, Mylan Inc. -- Cases -- Intellectual property, Sandoz Inc. -- Cases -- Intellectual property, Natco Inc. -- Cases -- Intellectual property, Teva Pharmaceutical Industries Ltd. -- Cases -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Tool industry -- Cases -- Intellectual property, Patent infringement -- Cases, Pharmaceutical industry -- Cases -- Intellectual property, Company legal issue, Business, General interest, Business, regional, Copaxone (Medication)
Abstract

Aug. 30--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) announced today that the US District Court for the Southern District of New York had issued a favorable set of rulings [...]

Published
2011

29. BRIEF: Teva, Novartis settle Lotrel patent case

Subjects
Amgen Inc. -- Cases -- Intellectual property, Novartis AG -- Cases -- Intellectual property, Teva Pharmaceutical Industries Ltd. -- Cases -- Intellectual property, Generic drugs -- Cases, Biotechnology industry -- Cases -- Intellectual property, Patent infringement -- Cases, Pharmaceutical industry -- Cases -- Intellectual property, Company legal issue, Business, General interest, Business, regional, Lotrel (Medication)
Abstract

Byline: Shiri Habib-Valdhorn July 24--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) has settled the patent infringement suit filed by Novartis over Teva's generic version of Lotrel, a treatment for [...]

Published
2011

30. Successful Use Of Inter Partes Review To Cancel Claims Asserted In Parallel Litigation

Author

Norton, Vicki

Subjects
Illumina Inc. -- Cases -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Patent infringement -- Cases, Company legal issue, Business, international, Columbia University -- Cases
Abstract

In a trio of March 6, 2014 inter partes review (IPR) decisions, the Patent Trial and Appeal Board (PTAB) canceled patent claims related to next generation DNA sequencing technology, after [...]

Published
2014

31. The Myriad Decision: Has The Dust Settled Yet?

Subjects
United States. Patent and Trademark Office -- Trade policy, Biological products -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Company legal issue, Business, international
Abstract

Six months ago, the United States Supreme Court shook up the biotechnology industry by ruling that genetic sequences are not patent eligible 'simply because they have been isolated.' AMP v. [...]

Published
2014

32. Fetal tests spur legal battle: a newborn industry based on non-invasive genetic testing turns combative

Author

Hayden, Erika Check

Subjects
Medical tests -- Market size, Biotechnology industry -- Cases -- Intellectual property, Prenatal diagnosis -- Equipment and supplies, Pregnant women -- Medical examination, Patent infringement -- Cases, Genetic screening -- Market size, Company legal issue, Environmental issues, Science and technology, Zoology and wildlife conservation
Abstract

Genetic tests that analyse fetal DNA from a pregnant woman's blood are arriving in a rush, giving parents powerful tools for gleaning information about their unborn offspring. Three companies have [...]

Published
2012

33. 'Patent trolls' target biotechnology firms: opportunistic patent litigation threatens the life sciences

Author

Hayden, Erika Check

Subjects
Biotechnology industry -- Cases -- Intellectual property, Patent infringement -- Cases -- Forecasts and trends, Company legal issue, Market trend/market analysis, Environmental issues, Science and technology, Zoology and wildlife conservation
Abstract

The biotechnology industry has had its share of woes, but so far 'patent trolls' have not numbered among them. These companies, which profit by legally enforcing patents they own rather [...]

Published
2011

34. Patenting of genes

Subjects
Myriad Genetics Inc. -- Cases -- Intellectual property, Patent law -- Cases, Biotechnology industry -- Cases -- Intellectual property, BRCA mutations -- Intellectual property, Company legal issue, Biological sciences, Health, American Civil Liberties Union -- Cases
Abstract

Oct 29 In a surprise reversal, the US government came out against the patenting of genes. The government filed an amicus brief in an ongoing federal court case brought by [...]

Published
2010

35. Legal battle may reshape nanotechnology firm

Author

Sanderson, Katharine

Subjects
Oxonica Ltd. -- Cases -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Nanotechnology -- Intellectual property -- Cases, Patent infringement -- Cases, Environmental issues, Science and technology, Zoology and wildlife conservation, Company legal issue, Intellectual property, Cases
Abstract

Oxonica, one of the United Kingdom's leading nanotechnology companies (see Nature 446, 963; 2007), has lost its latest legal fight over intellectual-property rights to a fuel additive. On 9 July, [...]

Published
2009

36. Biotech nightmare: does Cetus own PCR?

Author

Barinaga, Marcia

Subjects
E.I. du Pont de Nemours and Co. -- Cases -- Intellectual property, Cetus Corp. -- Intellectual property -- Cases, Biotechnology industry -- Cases -- Intellectual property, Polymerase chain reaction -- Intellectual property -- Cases, Science and technology, Company legal issue, Intellectual property, Cases
Abstract

FOR A BIOTECH COMPANY STRUGGLING TO build applications out of basic research, the main problem is getting a product on the market. Cetus Corporation solved that problem in a big [...]

Published
1991

37. Patent crunch pending: drug makers are fighting a rear-guard action against patent laws that are before the US Congress

Author

Wadman, Meredith

Subjects
Patent law -- Evaluation -- Cases, Diabetes -- Care and treatment -- Cases, Biotechnology industry -- Cases -- Intellectual property, Insulin -- Intellectual property -- Cases -- Evaluation, Inhaled medication -- Intellectual property -- Cases, Environmental issues, Science and technology, Zoology and wildlife conservation, Company legal issue, Care and treatment, Evaluation, Intellectual property, Cases
Abstract

The biotechnology firm Alkermes in Cambridge, Massachusetts, has made a big bet on a simple idea: that patients with diabetes should be able to inhale, rather than inject, their insulin. [...]

Published
2007

38. Dr Reddy's Laboratories sued over cancer drug patent

Subjects
Genzyme Corp. -- Cases -- Intellectual property, Sanofi S.A. -- Cases -- Intellectual property, Generic drugs -- Cases, Antineoplastic agents -- Cases, Biotechnology industry -- Cases -- Intellectual property, Cancer -- Care and treatment, Drug approval -- Cases, Patent infringement -- Cases, Antimitotic agents -- Cases, Pharmaceutical industry -- Cases -- Intellectual property, Company legal issue, Biotechnology industry
Abstract

Sanofi-Aventis' fully owned subsidiary - Genzyme Corporation, has filed a suit against Dr Reddy's Laboratories, alleging that it has infringed on patents of its cancer drug Mozobil (Plerixafor injection) on [...]

Published
2013

39. Precision BioSciences Files Patent Infringement Lawsuit against Lonza Related to GS XceedTM Gene Expression System

Subjects
Gene expression -- Cases, Genomics -- Cases, Biotechnology industry -- Cases -- Intellectual property, Patent infringement -- Cases, Company legal issue, Business, Business, international
Abstract

RESEARCH TRIANGLE PARK, N.C. -- Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that it has filed a patent infringement lawsuit against Lonza Group (LONN.VX) [...]

Published
2013

40. Appeal lodged in gene patents decision

Subjects
Myriad Genetics Inc. -- Cases -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Nonprofit organizations -- Cases, Patents -- Cases, Company legal issue, Patent/copyright issue, Business, international
Abstract

> Cancer Voices Australia v Myriad Genetics Inc [2013] FCA 65 On 15 February 2013, Justice Nicholas of the Federal Court of Australia delivered the first Australian decision regarding the [...]

Published
2013

41. Myriad Posts Gene Patenting Victory In Australia

Subjects
Myriad Genetics Inc. -- Cases -- Intellectual property, Consumer groups -- Cases, Patentability -- Cases, Biotechnology industry -- Cases -- Intellectual property, Company legal issue, Business, international
Abstract

In a companion case to the 'gene patenting' dispute presently before the U.S. Supreme Court, Myriad Genetics, Inc. successfully defended the patent-eligibility of 'gene patents' in Australia. In Cancer Voices [...]

Published
2013

42. Federal Circuit Reaffirms Patent Eligibility Of Isolated DNA Molecules

Subjects
Myriad Genetics Inc. -- Cases -- Intellectual property, Prometheus Laboratories Inc. -- Cases, Biotechnology industry -- Cases -- Intellectual property, Scientific societies -- Cases, Drugs -- Intellectual property, Health care industry -- Cases, Patents -- Cases, Pharmaceutical industry -- Cases, Company legal issue, Health care industry, Patent/copyright issue, Business, international
Abstract

On August 16, 2012, the U.S. Court of Appeals for the Federal Circuit issued its decision in Association for Molecular Pathology v. Myriad Genetics, Inc. ('Myriad II') following a remand [...]

Published
2013

43. 3 More Biotech Firms File Suit Against Columbia Over Patent

Author

Pollack, Andrew

Subjects
Company legal issue, Patent/copyright issue, Genzyme Corp. -- Cases -- Intellectual property, Columbia University -- Cases -- Intellectual property, Copyright -- Cases, Biotechnology industry -- Cases -- Intellectual property, Patents -- Cases
Abstract

Columbia University is coming under increasing legal attack from biotechnology companies, which accuse it of illegally trying to extend the life of a patent that has brought the institution hundreds […]

Published
2003

44. Europeans revoke patent on enzyme

Subjects
Company legal issue, Government regulation, Promega Corp. -- Cases -- Intellectual property -- Laws, regulations and rules, Roche Holding AG -- Intellectual property -- Laws, regulations and rules -- Cases, European Patent Organisation. European Patent Office -- Laws, regulations and rules -- Cases, Biochemistry -- Cases, Biological products industry -- Intellectual property -- Cases, Biotechnology industry -- Cases -- Intellectual property, Drugs -- Cases, Enzymes -- Intellectual property -- Cases, Pharmaceutical industry -- Intellectual property -- Cases
Abstract

The European Patent Office revoked a patent yesterday held by Roche on an enzyme crucial to one of the biotechnology industry's fundamental processes, executives said. The enzyme, known as Taq […]

Published
2001

45. Patent on small yellow bean provokes cry of biopiracy

Author

Pratt, Timothy

Subjects
Company legal issue, Patent/copyright issue, Pod-ners -- Intellectual property, Plant genetics -- Cases, Mimosaceae -- Intellectual property -- Cases, Agricultural industry -- Intellectual property -- Cases, Biotechnology industry -- Cases -- Intellectual property, Legumes -- Intellectual property -- Cases, Patents -- Cases, Beans -- Intellectual property -- Cases, Dried beans -- Cases
Abstract

Dr. Joachim Voss has a quick smile and easy laugh, but he has decided to pick a fight in his new job as director of one of the agricultural research […]

Published
2001

46. A coming court test on whether corn seed and mathematical instructions have similar status

Author

Chartrand, Sabra

Subjects
Company legal issue, Patent/copyright issue, J.E.M. AG Supply -- Cases, Hi-bred International Inc. -- Cases -- Intellectual property, Corn -- Cases, Corn industry -- Intellectual property -- Cases, Biotechnology industry -- Cases -- Intellectual property, Genetic engineering -- Cases, Patents -- Cases
Abstract

AFTER agreeing last month to hear a dispute between two corn-seed companies struggling for economic advantage in the lucrative market for genetically engineered plants, the United States Supreme Court is […]

Published
2001

47. Genetic Technologies files patent infringement suit against Reproductive Genetics Institute Inc in US

Subjects
Genetic Technologies Ltd. -- Cases -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Noncoding DNA -- Cases, Patent infringement -- Cases, Company legal issue, Business, Chemicals, plastics and rubber industries
Abstract

Genetic Technologies Ltd has filed a patent infringement suit in respect of its non-coding DNA technologies against Reproductive Genetics Institute Inc in the US District Court, for the Northern District [...]

Published
2012

48. Decision Compelling Arbitration Affirmed Where Valid Agreement Exists

Subjects
Promega Corp. -- Cases -- Intellectual property, Life Technologies Corp. -- Cases -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Patent infringement -- Cases, Company legal issue, Business, international
Abstract

This article previously appeared in Last Month at the Federal Circuit, April 2012 Judges: Rader, Newman (dissent), Dyk (author) [Appealed from W.D. Wis.. Judge Crabb] In Promega Corporation v. Life [...]

Published
2012

49. Genetic Technologies settles patent infringement lawsuit against Eurofins STA for non-coding patents

Subjects
Genetic Technologies Ltd. -- Cases -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Patent infringement -- Cases, Company legal issue, Banking, finance and accounting industries, Business, general
Abstract

Feb 07, 2012 (Datamonitor Financial Deals Tracker via COMTEX) -- Genetic Technologies Limited, an Australian life science company, has signed a settlement agreement with Eurofins STA Laboratories, Inc. for its [...]

Published
2012

50. Alnylam Pharmaceuticals files patent infringement lawsuit against Tekmira Pharmaceuticals

Subjects
Alnylam Pharmaceuticals Inc. -- Cases -- Intellectual property, Biotechnology industry -- Cases -- Intellectual property, Patent infringement -- Cases, Pharmaceutical industry -- Cases -- Intellectual property, Company legal issue, Banking, finance and accounting industries, Business, general
Abstract

Jan 18, 2012 (Datamonitor Financial Deals Tracker via COMTEX) -- Alnylam Pharmaceuticals, Inc., a US-based biopharmaceutical company, has filed a patent infringement lawsuit against Tekmira Pharmaceuticals Corporation in the US [...]

Published
2012

Catalog

Books, media, physical & digital resources
See catalog results